期刊文献+

应对超级细菌的治疗药物 被引量:3

下载PDF
导出
摘要 2010年8月,著名医学杂志Lancet Infection Dis(《柳叶刀感染病学》)发表一项研究称,发现新的耐药病原菌,称为“新德里-金属-β-内酰胺酶1(NDM-1)”基因的耐药菌。这种耐药菌能够分解碳青霉烯类抗菌药。该病原菌标本分离,经聚合酶链反应(PCR)确认为携NDM-1基因,来自印度、巴基斯坦、英国。而且发现NDM-1大多存在于大肠杆菌和肺炎克雷伯杆菌中。
作者 陈冠容
机构地区 武汉市普爱医院
出处 《药物流行病学杂志》 CAS 2011年第2期97-99,113,共4页 Chinese Journal of Pharmacoepidemiology
  • 相关文献

参考文献12

  • 1Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study[J]. Lancet Infect Dis, 2010,10(9) :597-602.
  • 2张祎博,倪语星,孙景勇,朱德妹,胡付品,汪复,蒋晓飞,俞云松,杨青,孙自镛,简翠,徐英春,孙宏莉,胡云建,艾效曼,单斌,杜艳,苏丹虹,卓超,徐元宏,沈继录,王传清,王爱敏,贾蓓,黄文祥,魏莲花,吴玲,张朝霞,季萍,张泓,李万华.2009年中国CHINET铜绿假单胞菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):436-440. 被引量:74
  • 3张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 4Mendes RE, Bell JM, Tumidge JD, et al. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program [ J ]. Antimicrob Agents Chemother,2009,63 ( 1 ) : 55-59.
  • 5Hermsen ED, Sullivan C J, Rotschafer JC. Polymyxins : pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications [ J ]. Infect Dis Clin North Am, 2003, 17(3): 545-562.
  • 6Levin AS, Barone AA, Penco J, et al. Intravenous Colistin as Therapy for Nosocomial Infections Caused by Muhidrug- Resistant Pseudomonas aeruginosa and Acinetobacter baumannii [ J ]. Clin Infect Dis, 1999,28 ( 5 ) : 1008-1011.
  • 7Kaller H, Hergafi L, Bahloul M, et al. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia:a matched case control study[ J ]. Intensive Care Med ,2007 ,33 : 1162-1167.
  • 8Kasiakou SK, Michalopoulos A, Soteriades ES,et al. Combination Therapy with Intravenous Colistin for Management of Infections Due to Muhidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis[ J ]. Antimicrob Agents Chemother,2005,49( 8 ) : 3136-3146.
  • 9Castanheira M, Sader HS, Deshpande LM,et al. Antimicro- bial Activities of Tigecycline and Other Broad-Spectrum Antimicrobials Tested against Serine Carbapenemase-and Metallo-β-Lactamase-Producing Enterobacteriaceae : Report from the SENTRY Antimicrobial Surveillance Program [ J ]. Antimicrob Agents Chemother, 2008,52 (2) : 570-573.
  • 10Hoban DJ, Bouchillon SK, Johnson BM, et al. In vitro activity of tigecycline against 6792 Gram-negative and Grampositive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial ( TEST Program, 2004) [ J ]. Diagn Microbiol Infect Dis, 2005, 52(3) : 215-227.

二级参考文献3

共引文献201

同被引文献30

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部